Roche Holding AG (OTCMKTS:RHHBY) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Roche Holding AG (OTCMKTS:RHHBY) have been given an average recommendation of “Moderate Buy” by the nine brokerages that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, two have given a buy recommendation and three have assigned a strong buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $57.00.

Several research analysts have weighed in on the stock. HSBC reissued a “buy” rating and issued a $57.00 price target on shares of Roche in a report on Wednesday, December 10th. JPMorgan Chase & Co. upgraded Roche from an “underweight” rating to a “neutral” rating in a research note on Monday, December 8th. Hsbc Global Res upgraded Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 2nd. Zacks Research upgraded Roche from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Finally, Deutsche Bank Aktiengesellschaft raised Roche from a “sell” rating to a “hold” rating in a report on Tuesday, November 11th.

Roche Stock Up 1.2%

Shares of RHHBY opened at $53.40 on Friday. The company’s 50-day moving average is $48.68 and its 200-day moving average is $43.90. The company has a debt-to-equity ratio of 0.80, a current ratio of 1.29 and a quick ratio of 1.02. Roche has a fifty-two week low of $34.75 and a fifty-two week high of $53.54.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in RHHBY. Rhumbline Advisers raised its position in shares of Roche by 7.4% in the first quarter. Rhumbline Advisers now owns 107,252 shares of the company’s stock valued at $4,413,000 after buying an additional 7,374 shares in the last quarter. OLD National Bancorp IN increased its stake in Roche by 2.9% during the 2nd quarter. OLD National Bancorp IN now owns 261,317 shares of the company’s stock worth $10,604,000 after acquiring an additional 7,326 shares during the period. Enterprise Financial Services Corp acquired a new position in Roche in the 2nd quarter valued at $208,000. North Star Asset Management Inc. lifted its position in shares of Roche by 52.0% during the 2nd quarter. North Star Asset Management Inc. now owns 26,305 shares of the company’s stock valued at $1,072,000 after acquiring an additional 9,000 shares during the period. Finally, FineMark National Bank & Trust bought a new stake in shares of Roche during the 2nd quarter valued at $210,000.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.